Leukemic-CSCs with increased FAO and upregulated CD36 (FA transporter) expression exhibit chemoresistance while in vivo and ex vivo studies with CD36 knockout cells showed decreased tumor size when injected in mice. The gene discussed is CD36; the disease is neoplasm.